课题基金 / 基金详情

Data Analytics for High Throughput Drug Screens

Data Analytics for High Throughput Drug Screens
高通量药物筛选的数据分析
批准号:
2228034
负责人:
Kevin Leder
金额:
$54.29万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-01 至 2026-05-31

项目摘要

项目成果

Kevin Leder的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This grant will contribute to the advancement of national prosperity and economic welfare by developing techniques for the design and implementation of precision drug treatments for cancer patients. A single tumor typically contains heterogenous cells that differ in their response to different drug treatments. Even small subpopulations of drug-resistant cells may cause tumor recurrence and therapeutic failure. The project will develop tools to identify the distinct sub-populations of cells present in the tumor based on its response to therapy, leading to personalized treatment plans for cancer patients and the development of new methodologies for deconvolution of mixed signals. The associated educational activities will include mentoring graduate and undergraduate students, developing course content related to the work, and short summer school for high-school students.This grant will use the differential response of the sub-populations to the drug under study to identify subpopulations and quantify their initial fraction as well as their individual dose response. Models assuming no interactions between the sub-populations as well as models with both linear and nonlinear interactions will be considered. This requires the formulation of statistical inference problems based upon approximations of the likelihood function of sample path trajectories of non-Markovian process models capturing the underlying cellular population dynamics. Identifying estimates of the parameters requires solving constrained optimization problems with highly nonlinear and non-convex objective functions.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pcbi.1011888
发表时间: 2024-03-01
期刊: PLOS COMPUTATIONAL BIOLOGY
影响因子: 4.3
作者: [Wu,Chenyu, Gunnarsson,Einar Bjarki, Leder,Kevin]
通讯作者: Leder,Kevin
A comparison of mutation and amplification-driven resistance mechanisms and their impacts on tumor recurrence
突变和扩增驱动的耐药机制的比较及其对肿瘤复发的影响
DOI: 10.1007/s00285-023-01992-8
发表时间: 2023
期刊: Journal of Mathematical Biology
影响因子: 1.9
作者: [Li, Aaron, Kibby, Danika, Foo, Jasmine]
通讯作者: Foo, Jasmine
CAREER: Rare Events in Cancer Evolution
  • 批准号:
    1552764
  • 项目类别:
    Standard Grant
  • 资助金额:
    $50.0万
  • 财政年份:
    2016
  • 负责人:
    Kevin Leder
  • 依托单位:
New Mathematical Models for Optimal Anti-Cancer Therapy
  • 批准号:
    1362236
  • 项目类别:
    Standard Grant
  • 资助金额:
    $27.72万
  • 财政年份:
    2014
  • 负责人:
    Kevin Leder
  • 依托单位:
海外基金